Report

  1. Home
  2. Discounted reports

Generative Ai In Healthcare Market By Application (Treatment, Diagnosis, Drug Discovery, Research), By End User (Hospitals and clinics, Healthcare Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Market Report I 2023-11-01 I 250 Pages I Allied Market Research
Discounted by 10% to 2024-11-15

The global generative AI in healthcare market size was valued at $1.6 billion in 2022 and is projected to reach $30.4 billion by 2032, growing at a CAGR of 34.9% from 2023 to 2032.Generative AI has gained significant traction in the field of healthcare, revolutionizing various aspects of patient care, medical research, and administrative processes. One of its most notable applications is in medical image generation. Additionally, generative AI is being used to predict patient outcomes by generating synthetic patient data that can help researchers better understand disease progression and treatment effects while ensuring patient privacy. In the clinical domain, generative AI is assisting in medical record summarization and report generation. Natural Language Processing (NLP) models can generate concise and relevant summaries of patients' medical histories, aiding healthcare providers in making more informed decisions. Furthermore, chatbots and virtual assistants powered by generative language models offer support for patients, answering questions and providing information on various healthcare topics. Key factors driving the growth of generative AI in the healthcare market are the surge in the adoption of generative AI in healthcare in medical imaging, and the efficiency of generative AI in healthcare in clinical data management.
Generative AI has emerged as a transformative force in the field of healthcare, with its applications in medical imaging standing out as a major driver for the growth of generative AI in the healthcare market. One of the most compelling applications of generative AI in medical imaging is in the enhancement and reconstruction of medical images. Generative Adversarial Networks (GANs) and other generative models can improve the resolution and quality of images, aiding clinicians in making more accurate diagnoses. For instance, according to a 2023 report by the National Library of Medicine, generative artificial intelligence (AI) has shown great potential in enhancing medical imaging tasks such as data augmentation, image synthesis, image-to-image translation, and radiology report generation.
Furthermore, the efficiency of generative AI in healthcare in clinical data management is expected to contribute significantly to the growth of the market. Generative AI, powered by advanced natural language processing and machine learning techniques, has proven itself invaluable in transforming the way healthcare institutions handle and utilize vast volumes of clinical data. One of the most compelling aspects of generative AI is its ability to automate and streamline complex data management tasks. Generative AI can extract, organize, and categorize clinical data from a variety of sources, including electronic health records, medical imaging, and patient notes, with remarkable speed and precision. This not only reduces the burden on healthcare professionals, allowing them to focus more on patient care, but also significantly enhances the accuracy and completeness of data, which is crucial for evidence-based decision-making, research, and personalized patient treatment plans. For instance, in 2021, HCA Healthcare, Inc., one of the leading healthcare providers, and Google Cloud announced a multi-year strategic partnership. HCA Healthcare collaborated with Google Cloud on the use of generative AI to support doctors and nurses to reduce the burden of administrative tasks.
Moreover, generative AI's efficiency extends beyond data organization. It can generate comprehensive clinical reports, summaries, and predictive models by synthesizing information from disparate sources. This capability not only saves time but also aids in early disease detection, treatment optimization, and prognosis assessment. Additionally, its ability to continually learn and adapt from new data ensures that healthcare organizations stay up-to-date with the latest medical research and best practices, ultimately leading to improved patient outcomes. However, concerns related to data privacy might restrain the growth of the market.
The generative AI in healthcare market is segmented on the basis of application, end user, and region. By applications, the market is categorized into treatment, diagnosis, drug discovery, and research. As per end users, the market is categorized into hospitals & clinics, healthcare organizations, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global generative AI in the healthcare market are IBM Watson Health Corporation, Google LLC, Syntegra, Amazon, Open AI, NVIDIA Corporation, Oracle, Insilico Medicine, Abridge AI Inc, and Microsoft.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the generative AI in healthcare market analysis from 2022 to 2032 to identify the prevailing generative ai in healthcare market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the generative ai in healthcare market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global generative AI in healthcare market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- SWOT Analysis
Key Market Segments
By Application
- Treatment
- Diagnosis
- Drug Discovery
- Research
By End User
- Hospitals and clinics
- Healthcare Organizations
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- IBM Watson Health Corporation
- Amazon
- Microsoft
- Open AI Inc.
- Google LLC
- NVIDIA Corporation
- Abridge AI Inc.
- Syntegra
- InSilico Medicine
- Oracle

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in adoption of generative AI in healthcare in medical imaging.
3.4.1.2. Efficiency of generative AI in workflow and administrative tasks.
3.4.1.3. Use of generative AI in personalized medicine.
3.4.2. Restraints
3.4.2.1. Data privacy and security risk.
3.4.3. Opportunities
3.4.3.1. Use of generative AI in drug discovery development
CHAPTER 4: GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Treatment
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Diagnosis
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Drug Discovery
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Research
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: GENERATIVE AI IN HEALTHCARE MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals and clinics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Healthcare Organizations
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: GENERATIVE AI IN HEALTHCARE MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Application
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Application
6.2.4.1.2. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Application
6.2.4.2.2. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Application
6.2.4.3.2. Market size and forecast, by End User
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Application
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Application
6.3.4.1.2. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Application
6.3.4.2.2. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Application
6.3.4.3.2. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Application
6.3.4.4.2. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Application
6.3.4.5.2. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Application
6.3.4.6.2. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Application
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Application
6.4.4.1.2. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Application
6.4.4.2.2. Market size and forecast, by End User
6.4.4.3. Australia
6.4.4.3.1. Market size and forecast, by Application
6.4.4.3.2. Market size and forecast, by End User
6.4.4.4. India
6.4.4.4.1. Market size and forecast, by Application
6.4.4.4.2. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Application
6.4.4.5.2. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Application
6.4.4.6.2. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Application
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Application
6.5.4.1.2. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Application
6.5.4.2.2. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Application
6.5.4.3.2. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Application
6.5.4.4.2. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Syntegra
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Key strategic moves and developments
8.2. IBM Watson Health Corporation
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Google LLC
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Amazon
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Oracle
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.6. Microsoft
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. NVIDIA Corporation
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. InSilico Medicine
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Abridge AI Inc.
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. Open AI Inc.
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. GENERATIVE AI IN HEALTHCARE MARKET FOR TREATMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GENERATIVE AI IN HEALTHCARE MARKET FOR DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GENERATIVE AI IN HEALTHCARE MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GENERATIVE AI IN HEALTHCARE MARKET FOR RESEARCH, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 07. GENERATIVE AI IN HEALTHCARE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GENERATIVE AI IN HEALTHCARE MARKET FOR HEALTHCARE ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GENERATIVE AI IN HEALTHCARE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GENERATIVE AI IN HEALTHCARE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 11. NORTH AMERICA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 12. NORTH AMERICA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA GENERATIVE AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 14. U.S. GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 15. U.S. GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. CANADA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 17. CANADA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 18. MEXICO GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. MEXICO GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. EUROPE GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 21. EUROPE GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 22. EUROPE GENERATIVE AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 23. GERMANY GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. GERMANY GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. FRANCE GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. FRANCE GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. UK GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. UK GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. ITALY GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. ITALY GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 31. SPAIN GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. SPAIN GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. REST OF EUROPE GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. REST OF EUROPE GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 35. ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 38. JAPAN GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. JAPAN GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. CHINA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. CHINA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. AUSTRALIA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. AUSTRALIA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 44. INDIA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. INDIA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. SOUTH KOREA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. SOUTH KOREA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 50. LAMEA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. LAMEA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. LAMEA GENERATIVE AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. BRAZIL GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. BRAZIL GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. SAUDI ARABIA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. SAUDI ARABIA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. SOUTH AFRICA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. SOUTH AFRICA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. REST OF LAMEA GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. REST OF LAMEA GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. SYNTEGRA: KEY EXECUTIVES
TABLE 62. SYNTEGRA: COMPANY SNAPSHOT
TABLE 63. SYNTEGRA: PRODUCT SEGMENTS
TABLE 64. SYNTEGRA: PRODUCT PORTFOLIO
TABLE 65. SYNTEGRA: KEY STRATERGIES
TABLE 66. IBM WATSON HEALTH CORPORATION: KEY EXECUTIVES
TABLE 67. IBM WATSON HEALTH CORPORATION: COMPANY SNAPSHOT
TABLE 68. IBM WATSON HEALTH CORPORATION: PRODUCT SEGMENTS
TABLE 69. IBM WATSON HEALTH CORPORATION: PRODUCT PORTFOLIO
TABLE 70. GOOGLE LLC: KEY EXECUTIVES
TABLE 71. GOOGLE LLC: COMPANY SNAPSHOT
TABLE 72. GOOGLE LLC: SERVICE SEGMENTS
TABLE 73. GOOGLE LLC: PRODUCT PORTFOLIO
TABLE 74. GOOGLE LLC: KEY STRATERGIES
TABLE 75. AMAZON: KEY EXECUTIVES
TABLE 76. AMAZON: COMPANY SNAPSHOT
TABLE 77. AMAZON: PRODUCT SEGMENTS
TABLE 78. AMAZON: PRODUCT PORTFOLIO
TABLE 79. ORACLE: KEY EXECUTIVES
TABLE 80. ORACLE: COMPANY SNAPSHOT
TABLE 81. ORACLE: SERVICE SEGMENTS
TABLE 82. ORACLE: PRODUCT PORTFOLIO
TABLE 83. MICROSOFT: KEY EXECUTIVES
TABLE 84. MICROSOFT: COMPANY SNAPSHOT
TABLE 85. MICROSOFT: SERVICE SEGMENTS
TABLE 86. MICROSOFT: PRODUCT PORTFOLIO
TABLE 87. MICROSOFT: KEY STRATERGIES
TABLE 88. NVIDIA CORPORATION: KEY EXECUTIVES
TABLE 89. NVIDIA CORPORATION: COMPANY SNAPSHOT
TABLE 90. NVIDIA CORPORATION: PRODUCT SEGMENTS
TABLE 91. NVIDIA CORPORATION: PRODUCT PORTFOLIO
TABLE 92. NVIDIA CORPORATION: KEY STRATERGIES
TABLE 93. INSILICO MEDICINE: KEY EXECUTIVES
TABLE 94. INSILICO MEDICINE: COMPANY SNAPSHOT
TABLE 95. INSILICO MEDICINE: PRODUCT SEGMENTS
TABLE 96. INSILICO MEDICINE: PRODUCT PORTFOLIO
TABLE 97. ABRIDGE AI INC.: KEY EXECUTIVES
TABLE 98. ABRIDGE AI INC.: COMPANY SNAPSHOT
TABLE 99. ABRIDGE AI INC.: PRODUCT SEGMENTS
TABLE 100. ABRIDGE AI INC.: PRODUCT PORTFOLIO
TABLE 101. OPEN AI INC.: KEY EXECUTIVES
TABLE 102. OPEN AI INC.: COMPANY SNAPSHOT
TABLE 103. OPEN AI INC.: PRODUCT SEGMENTS
TABLE 104. OPEN AI INC.: PRODUCT PORTFOLIO

LIST OF FIGURES
FIGURE 01. GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GENERATIVE AI IN HEALTHCARE MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN GENERATIVE AI IN HEALTHCARE MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN GENERATIVE AI IN HEALTHCARE MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL GENERATIVE AI IN HEALTHCARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR TREATMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR RESEARCH, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. GENERATIVE AI IN HEALTHCARE MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR HEALTHCARE ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENERATIVE AI IN HEALTHCARE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. GENERATIVE AI IN HEALTHCARE MARKET BY REGION, 2022 AND 2032(%)
FIGURE 21. U.S. GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 22. CANADA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 23. MEXICO GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 24. GERMANY GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 25. FRANCE GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 26. UK GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 27. ITALY GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 28. SPAIN GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 29. REST OF EUROPE GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 30. JAPAN GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 31. CHINA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 32. AUSTRALIA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 33. INDIA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 34. SOUTH KOREA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 36. BRAZIL GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 37. SAUDI ARABIA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH AFRICA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF LAMEA GENERATIVE AI IN HEALTHCARE MARKET, 2022-2032 ($MILLION)
FIGURE 40. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 41. COMPETITIVE DASHBOARD
FIGURE 42. COMPETITIVE HEATMAP: GENERATIVE AI IN HEALTHCARE MARKET
FIGURE 43. TOP PLAYER POSITIONING, 2022
FIGURE 44. IBM WATSON HEALTH CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 45. IBM WATSON HEALTH CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 46. IBM WATSON HEALTH CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 47. GOOGLE LLC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 48. GOOGLE LLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. GOOGLE LLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 50. AMAZON: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. AMAZON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. AMAZON: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 54. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. MICROSOFT: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 57. MICROSOFT: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 58. MICROSOFT: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. NVIDIA CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 60. NVIDIA CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. NVIDIA CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 62. NVIDIA CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3456.00 $3110.40
  • $5730.00 $5157.00
  • $9600.00 $8640.00
  • ADD TO BASKET
  • BUY NOW